Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-28 Sale | 2022-09-30 4:23 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 100,000 | $41.23 | $4,122,670 | 1,324,700 (Indirect) | View |
| 2022-06-08 Sale | 2022-06-10 5:13 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 100,000 | $41.56 | $4,155,900 | 945,830 (Indirect) | View |
| 2022-05-27 Sale | 2022-05-31 5:23 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 75,000 | $41.08 | $3,081,008 | 1,045,830 (Indirect) | View |
| 2022-05-19 Sale | 2022-05-23 4:57 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 75,000 | $40.44 | $3,033,128 | 1,120,830 (Indirect) | View |
| 2021-07-26 Sale | 2021-07-27 5:25 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 8,949 | $39.78 | $355,977 | 1,195,830 (Indirect) | View |
| 2021-07-26 Sale | 2021-07-27 5:23 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 8,949 | $39.78 | $355,977 | 1,195,830 (Indirect) | View |
| 2021-07-12 Sale | 2021-07-14 5:17 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 17,934 | $42.01 | $753,369 | 1,204,779 (Indirect) | View |
| 2021-07-06 Sale | 2021-07-08 7:37 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 73,117 | $42.19 | $3,085,027 | 1,222,713 (Indirect) | View |
| 2021-06-04 Sale | 2021-06-08 8:12 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 200,000 | $45.55 | $9,110,689 | 1,295,830 (Indirect) | View |
| 2021-06-02 Sale | 2021-06-04 6:50 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 50,000 | $42.13 | $2,106,560 | 1,495,830 (Indirect) | View |
| 2021-04-14 Sale | 2021-04-16 5:56 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 55,714 | $42.1 | $2,345,593 | 225,030 (Indirect) | View |
| 2021-04-12 Sale | 2021-04-14 07:51 am | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 359 | $42.32 | $15,193 | 280,744 (Indirect) | View |
| 2021-03-22 Sale | 2021-03-24 5:25 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 43,927 | $46.32 | $2,034,519 | 281,103 (Indirect) | View |
| 2021-03-02 Sale | 2021-03-04 7:02 pm | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 100,000 | $46.92 | $4,692,158 | 325,030 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-12 Gift | 2022-09-30 4:23 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer | 2,400 | $0 | 1,324,700 (Indirect) | View |
| 2021-09-10 Gift | 2021-12-30 6:03 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 5,128 | $0 | 481,270 (Indirect) | View |
| 2021-05-07 Conversion | 2021-05-11 9:06 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 1,452,880 | $0 | 2,032,228 (Indirect) | View |
| 2020-12-31 Conversion | 2021-01-05 9:45 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 440,000 | $0 | 1,045,615 (Indirect) | View |
| 2020-06-18 Conversion | 2020-06-22 9:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 27,533 | $0 | 888,508 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 863,283 | $0 | 888,508 (Indirect) | View |
Ownership | 2020-06-15 9:25 pm | N/A N/A | Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments | 0 | $0 | 6,832,830 (Indirect) | View |